Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover effective US stock investment strategies tailored for beginners. Start your investment journey with confidence and knowledge.
23,568 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
SoftBank Group stock tumbled about 20% over the past five trading days as questions surrounding OpenAI funding and th...
Oil weakness adds pressure on Chevron as analysts weigh earnings visibility and cash returns. A rising risk of a drop...
Solana’s on-chain data show real-world asset transfers surging to $8.68 billion in the last 30 days, with asset value...
Applied Optoelectronics has jumped as AI buyers chase fast, fiber-based connectivity. The stock rally highlights how ...
Oil prices surge on supply concerns, pushing the S&P 500 lower as investors rotate into energy names. This stock mark...
Credo Technology stock sits near its 52-week peak as AI infrastructure demand remains robust. Investors are debating ...
In a dramatic 48-hour move, the world’s hottest stock market erased and then recovered a large portion of its gains, ...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
Micron stock retreats after a spring rally, renewing the debate over whether the memory chip maker has peaked. Analys...
Best Buy’s stock soaring after a solid earnings beat, even as sales disappointed and the company trimmed its full-yea...